Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 20 Apr 23 424B3 Prospectus supplement
- 12 Feb 20 424B4 Prospectus supplement with pricing info
- 12 Feb 20 EFFECT Notice of effectiveness
- 7 Feb 20 S-1/A IPO registration (amended)
-
31 Jan 20 S-1/A IPO registration (amended)
PHIO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Phio Pharmaceuticals Corp.
Marlborough, Massachusetts
We hereby consent to the incorporation by reference in the prospectus constituting a part of this Registration Statement of our report dated March 27, 2019, relating to the consolidated financial statements of Phio Pharmaceuticals Corp. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Boston, Massachusetts
January 31, 2020